345 related articles for article (PubMed ID: 23466711)
1. Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma.
Duggan C; Onstad L; Hardikar S; Blount PL; Reid BJ; Vaughan TL
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):934-43. PubMed ID: 23466711
[TBL] [Abstract][Full Text] [Related]
2. Dietary supplement use and risk of neoplastic progression in esophageal adenocarcinoma: a prospective study.
Dong LM; Kristal AR; Peters U; Schenk JM; Sanchez CA; Rabinovitch PS; Blount PL; Odze RD; Ayub K; Reid BJ; Vaughan TL
Nutr Cancer; 2008; 60(1):39-48. PubMed ID: 18444134
[TBL] [Abstract][Full Text] [Related]
3. Association between length of Barrett's esophagus and risk of high-grade dysplasia or adenocarcinoma in patients without dysplasia.
Anaparthy R; Gaddam S; Kanakadandi V; Alsop BR; Gupta N; Higbee AD; Wani SB; Singh M; Rastogi A; Bansal A; Cash BD; Young PE; Lieberman DA; Falk GW; Vargo JJ; Thota P; Sampliner RE; Sharma P
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1430-6. PubMed ID: 23707463
[TBL] [Abstract][Full Text] [Related]
4. Role of body composition and metabolic profile in Barrett's oesophagus and progression to cancer.
Di Caro S; Cheung WH; Fini L; Keane MG; Theis B; Haidry R; Di Renzo L; De Lorenzo A; Lovat L; Batterham RL; Banks M
Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):251-60. PubMed ID: 26671515
[TBL] [Abstract][Full Text] [Related]
5. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus.
Dong J; Levine DM; Buas MF; Zhang R; Onstad L; Fitzgerald RC; ; Corley DA; Shaheen NJ; Lagergren J; Hardie LJ; Reid BJ; Iyer PG; Risch HA; Caldas C; Caldas I; Pharoah PD; Liu G; Gammon MD; Chow WH; Bernstein L; Bird NC; Ye W; Wu AH; Anderson LA; MacGregor S; Whiteman DC; Vaughan TL; Thrift AP
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1598-1606.e4. PubMed ID: 29551738
[TBL] [Abstract][Full Text] [Related]
6. Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus.
Rubenstein JH; Morgenstern H; McConell D; Scheiman JM; Schoenfeld P; Appelman H; McMahon LF; Kao JY; Metko V; Zhang M; Inadomi JM
Gastroenterology; 2013 Dec; 145(6):1237-44.e1-5. PubMed ID: 23999171
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin and adiponectin levels and risk of Barrett's esophagus and intestinal metaplasia of the gastroesophageal junction.
Thompson OM; Beresford SA; Kirk EA; Bronner MP; Vaughan TL
Obesity (Silver Spring); 2010 Nov; 18(11):2204-11. PubMed ID: 20111023
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
9. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
Hardikar S; Onstad L; Blount PL; Odze RD; Reid BJ; Vaughan TL
PLoS One; 2013; 8(1):e52192. PubMed ID: 23300966
[TBL] [Abstract][Full Text] [Related]
10. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease.
Almers LM; Graham JE; Havel PJ; Corley DA
Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2256-64.e1-3. PubMed ID: 25632808
[TBL] [Abstract][Full Text] [Related]
12. Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium.
Petrick JL; Li N; Anderson LA; Bernstein L; Corley DA; El Serag HB; Hardikar S; Liao LM; Liu G; Murray LJ; Rubenstein JH; Schneider JL; Shaheen NJ; Thrift AP; van den Brandt PA; Vaughan TL; Whiteman DC; Wu AH; Zhao WK; Gammon MD; Cook MB
Cancer; 2019 Dec; 125(23):4210-4223. PubMed ID: 31490550
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal anti-inflammatory drugs and statins have chemopreventative effects in patients with Barrett's esophagus.
Kastelein F; Spaander MC; Biermann K; Steyerberg EW; Kuipers EJ; Bruno MJ;
Gastroenterology; 2011 Dec; 141(6):2000-8; quiz e13-4. PubMed ID: 21878200
[TBL] [Abstract][Full Text] [Related]
14. Incidence of adenocarcinoma among patients with Barrett's esophagus.
Hvid-Jensen F; Pedersen L; Drewes AM; Sørensen HT; Funch-Jensen P
N Engl J Med; 2011 Oct; 365(15):1375-83. PubMed ID: 21995385
[TBL] [Abstract][Full Text] [Related]
15. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus.
Thrift AP; Anderson LA; Murray LJ; Cook MB; Shaheen NJ; Rubenstein JH; El-Serag HB; Vaughan TL; Schneider JL; Whiteman DC; Corley DA
Am J Gastroenterol; 2016 Nov; 111(11):1528-1535. PubMed ID: 27575711
[TBL] [Abstract][Full Text] [Related]
16. Circulating inflammatory cytokines and adipokines are associated with increased risk of Barrett's esophagus: a case-control study.
Garcia JM; Splenser AE; Kramer J; Alsarraj A; Fitzgerald S; Ramsey D; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):229-238.e3. PubMed ID: 23954649
[TBL] [Abstract][Full Text] [Related]
17. A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High-Grade Dysplasia and Esophageal Cancer in Barrett's Esophagus.
Critchley-Thorne RJ; Davison JM; Prichard JW; Reese LM; Zhang Y; Repa K; Li J; Diehl DL; Jhala NC; Ginsberg GG; DeMarshall M; Foxwell T; Jobe BA; Zaidi AH; Duits LC; Bergman JJ; Rustgi A; Falk GW
Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):240-248. PubMed ID: 27729357
[TBL] [Abstract][Full Text] [Related]
18. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
[TBL] [Abstract][Full Text] [Related]
19. Esophageal adenocarcinoma in a first-degree relative increases risk for esophageal adenocarcinoma in patients with Barrett's esophagus.
Tofani CJ; Gandhi K; Spataro J; Yoo J; Murphy M; Mohan N; Daitch Z; Shah A; Janowski R; Huntley C; Dabbish N; Keith S; Coben R; Cohen S; Kastenberg D; Infantolino A
United European Gastroenterol J; 2019 Mar; 7(2):225-229. PubMed ID: 31080607
[TBL] [Abstract][Full Text] [Related]
20. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
